DNMT3B and breast neoplasm: Since overexpression of DNMT is thought to be an early event in carcinogenesis [42-44], elevated DNMT3b protein (which characterizes the hypermethylator phenotype in vitro) may constitute an important biomarker for early detection in patients developing breast tumors of the hypermethylator phenotype.